NBC
WST icon

Neuberger Berman Canada’s West Pharmaceutical WST Stock Holding History

Neuberger Berman Canada’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,414
Closed -$606K – 364
2017
Q2 		$606K Sell
6,414
-5,580
-47% -$513K 0.11% 245
2017
Q1 		$979K Buy
11,994
+8,959
+295% +$749K 0.19% 164
2016
Q4 		$257K Buy
+3,035
New +$239K 0.07% 212

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Neuberger Berman Canada's WST Position: Q3 2017 in Review

Neuberger Berman Canada sold out of West Pharmaceutical (WST) in Q3 2017, closing a stake of 6,414 shares — an estimated $606K sold.

Neuberger Berman Canada first reported a position in WST in Q4 2016 and held it in 3 quarters. The position peaked at $979K in Q1 2017. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

  • Neuberger Berman Canada reported no remaining West Pharmaceutical position as of Q3 2017 after selling out during the quarter.
  • Neuberger Berman Canada sold 6,414 West Pharmaceutical shares in Q3 2017, an estimated $606K.
  • Neuberger Berman Canada first reported a position in West Pharmaceutical in Q4 2016 and held it in 3 quarters.
  • Neuberger Berman Canada's West Pharmaceutical position peaked at $979K in Q1 2017.
  • 302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.